Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex strikes up AI collaboration with Volv

The duo will develop pharmacovigilance products and services

PharmaLexDevelopment consulting and affairs group PharmaLex has teamed up with privately held Volv Global to bolster its pharmacovigilance business.

The project will see the duo use artificial intelligence (AI) technology, such as Volv’s predictive technologies, unassisted machine learning, paradigms and web-scale technologies, to develop products and services for PharmaLex’s clients.

Dr Thomas Dobmeyer, chief executive officer of PharmaLex, said: “The increasing volume of relevant literature in the medico-scientific domain is a challenge.

“Embedded artificial intelligence and cognitive computing technology allows for increased efficiency, especially in the area of drug adverse even monitoring.

Initially focusing on pharmacovigilance services, the project will centre in on supporting and monitoring adverse events that recorded on web forums and social media channels, regulatory intelligence platforms, patient identification for rare diseases and related services.

Christopher Rudolf, founder and chief executive officer of Volv Global, said: “We are delighted to be working with PharmaLex on the development of their pharmacovigilance (PV) solutions.

“Our innovative technology has an open design and intuitive interface, ensuring it can easily integrate into existing PV platforms.”

Article by
Gemma Jones

6th September 2017

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics